- Home
- ROIV vs ALV Comparison
ROIV vs ALV Comparison
Compare ROIV & ALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- ALV
- Stock Information
- Founded
- ROIV 2014
- ALV 1953
- Country
- ROIV United Kingdom
- ALV Sweden
- Employees
- ROIV N/A
- ALV N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- ALV Auto Parts:O.E.M.
- Sector
- ROIV Health Care
- ALV Consumer Discretionary
- Exchange
- ROIV Nasdaq
- ALV Nasdaq
- Market Cap
- ROIV 8.6B
- ALV 9.7B
- IPO Year
- ROIV N/A
- ALV 1997
- Fundamental
- Price
- ROIV $18.28
- ALV $115.68
- Analyst Decision
- ROIV Strong Buy
- ALV Buy
- Analyst Count
- ROIV 8
- ALV 9
- Target Price
- ROIV $19.94
- ALV $131.33
- AVG Volume (30 Days)
- ROIV 7.5M
- ALV 732.2K
- Earning Date
- ROIV 11-11-2025
- ALV 10-17-2025
- Dividend Yield
- ROIV N/A
- ALV 2.94%
- EPS Growth
- ROIV N/A
- ALV 25.57
- EPS
- ROIV N/A
- ALV 9.69
- Revenue
- ROIV $23,233,000.00
- ALV $10,614,000,000.00
- Revenue This Year
- ROIV N/A
- ALV $4.45
- Revenue Next Year
- ROIV $320.50
- ALV $4.26
- P/E Ratio
- ROIV N/A
- ALV $11.94
- Revenue Growth
- ROIV N/A
- ALV 0.85
- 52 Week Low
- ROIV $8.73
- ALV $75.49
- 52 Week High
- ROIV $18.42
- ALV $129.54
- Technical
- Relative Strength Index (RSI)
- ROIV 87.01
- ALV 37.75
- Support Level
- ROIV $16.89
- ALV $115.26
- Resistance Level
- ROIV $18.42
- ALV $119.68
- Average True Range (ATR)
- ROIV 0.52
- ALV 2.90
- MACD
- ROIV 0.08
- ALV -0.60
- Stochastic Oscillator
- ROIV 95.44
- ALV 6.33
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About ALV Autoliv Inc.
Autoliv Inc is the world-wide leader in passive safety components and systems for the auto industry. Products include seat belts, frontal air bags, side-impact air bags, air bag inflators, and steering wheels. The Renault-Nissan-Mitsubishi alliance is the company's largest customer at 10% of 2023 revenue, with Stellantis accounting for 10% and Volkswagen 9%. At 34% of 2023 revenue, the Americas was Autoliv's largest geographic region, followed by Europe at 27%, China at 20%, and rest of world at 19%.